- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 67.07M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $50M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $50M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $407M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $420M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $781M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $775M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $6.2B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.27B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.43B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.47B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $8.56B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.59B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 67.4M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $15M |
| Capex | Q1 2025 · Mar 31, 2024 | $18M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $67M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $2.42B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $2.47B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.22 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.22 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $170M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $70M |
| Net Income | Q1 2025 · Mar 31, 2024 | $15M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $106M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $415M |
| Revenue | Q1 2025 · Mar 31, 2024 | $868M |